The chronic obstructive pulmonary disease (COPD) drug delivery devices have garnered significant popularity in the past few decades, owing to consistent advancements in technology and development of innovative products. Inhaled medication has emerged as one of the most reliable and effective treatments for a broad range of respiratory diseases such as COPD and asthma. Within the COPD drug delivery devices market, focus on product innovation has gained significant momentum in the past 60 years - beginning from the advent of pressurized metered-dose inhalers. At present, although more than 230 devices and drug formulations are available, disease control continues to remain a major challenge.
Stakeholders operating in the current COPD drug delivery devices market are expected to focus on the development of innovative inhalers to improve the overall effectiveness of the inhaled medication therapy. Some of the innovations that are likely to take place within the COPD drug delivery devices market are expected to focus on digital technologies linked with inhalers, chemistry and formulations, and design and device engineering. Moreover, research and development activities are being undertaken to improve targeted drug delivery to the lungs. Furthermore, significant rise in the number of patients suffering from chronic obstructive pulmonary diseases worldwide coupled with a surge in demand for easy-to-operate devices is expected to drive the COPD drug delivery devices market to a value of US$ 11 Bn by 2027.
In the current COPD drug delivery devices market landscape, digital drug delivery devices are garnering significant popularity. Trends suggest a gradual shift toward improved digital inhalation devices primarily used to treat patients suffering from respiratory diseases, including asthma and COPD. In recent times, focus on the development of novel drug delivery devices and systems has gained significant momentum in the pharmaceutical sector. In their bid to improve patient outcomes, stakeholders operating in the current market space are increasingly focusing on product development by adopting a patient-centric model.
Key players operating in the COPD drug delivery devices market are enhancing the designs of conventional drug delivery devices to improve patient outcomes. In terms of type, the digital devices segment is expected to grow at a CAGR of ~5% during the forecast period (2019-2027), a higher CAGR growth than the manual devices segment, which is poised to grow at a CAGR of 3.8% during the forecast period. Increase in the adoption of digital COPD drug delivery devices is expected to address the problems that conventional drug delivery techniques were incompetent in solving.
Drug development pertaining to asthma has predominantly focused on new molecules in established classes, formulation of new devices, and a range of combination treatments. However, obtaining the approval of the FDA for these new COPD drug delivery devices is likely to remain a key for participants in the COPD drug delivery devices market landscape. In their efforts to establish a strong foothold in the market, several companies are launching new products with innovative designs and improved digital capabilities.
For instance, Lonza launched Capsugel ® Zephyr ™ - a new addition to the dry-powder inhalation capsule portfolio of the company. The company revealed that the launch of the new product was primarily aimed at fulfilling the growing demand for customized treatments for efficient COPD drug delivery.
While some stakeholders are adopting the strategy of product launches, others are actively engaged in seeking approval from the FDA. For instance, in December 2018, Teva announced that the FDA had approval its ProAir Digihaler COPD drug delivery device. The new device makes use of advanced sensors that can be connected to a mobile App, and is specifically developed for individuals suffering from COPD and asthma. The approval of this product is expected to provide an impetus for the adoption of digital technologies to develop cutting-edge COPD drug delivery devices. The COPD drug delivery devices market is a consolidated market with leading players, including Boehringer Ingelheim, GlaxoSmithKline plc, and AstraZeneca accounting for a collective market share of ~82% in 2018.
Analysts’ Viewpoint
The global COPD drug delivery devices market is expected to expand at a CAGR of 3.8% during the forecast period. This growth of the market can be attributed to the significant progress made in product development and integration of new digital technologies in the new-age COPD drug delivery devices. Stakeholders operating in the current market landscape should focus on gaining market share by acquiring small to mid-sized companies. North America and Europe will continue to remain the most prominent regions in the market, owing to favorable regulatory policies, focus on research and development, and growing investments toward product innovation and development. The COPD drug delivery devices in the Asia Pacific region is expected to witness the fastest CAGR growth of ~5%, as awareness related to the benefits of digital COPD drug delivery devices will continue to grow.
COPD Drug Delivery Devices Market - Segmentation
TMR’s study on the global COPD drug delivery devices market includes information divided into four segments: product, type, distribution channel, and region. Changing industry trends and other crucial market dynamics associated with these segments of the COPD drug delivery devices market have been discussed in detail.
|
Product |
|
|
Type |
|
|
Distribution Channel |
|
|
Region |
|
COPD drug delivery devices market to a value of US$ 11 Bn by 2027
COPD drug delivery devices market is projected to expand at a CAGR of 3.8% from 2019 to 2027
COPD drug delivery devices market is driven by rise in prevalence of COPD and awareness about COPD treatment
North America accounted for a major share of the global COPD drug delivery devices market, owing to the introduction of new drugs
Key players in the global COPD drug delivery devices market include Novartis AG, Teva Pharmaceutical Industries, Merck & Co., Inc., Cipla Inc., Sunovion Pharmaceuticals
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global COPD Drug Delivery Devices Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global COPD Drug Delivery Devices Market Analysis and Forecast, 2017–2027
5. Key Insights
5.1. Disease Prevalence in Key Countries
5.2. Key Market Events
5.3. Regulatory Scenario
6. Global COPD Drug Delivery Devices Market Analysis and Forecasts, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
6.3.1. Inhaler
6.3.1.1. Metered Dose Inhaler
6.3.1.2. Dry Powder Inhaler
6.3.1.3. Soft Mist Inhaler
6.3.2. Nebulizer
6.3.2.1. Jet Nebulizer
6.3.2.2. Mesh Nebulizer
6.3.2.3. Ultrasonic Nebulizer
6.4. Global COPD Drug Delivery Devices Market Attractiveness, by Product
7. Global COPD Drug Delivery Devices Market Analysis and Forecasts, by Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global COPD Drug Delivery Devices Market Value (US$) Forecast, by Type, 2017–2027
7.3.1. Manual Device
7.3.2. Digital Device
7.4. Global COPD Drug Delivery Devices Market Attractiveness, by Type
8. Global COPD Drug Delivery Devices Market Analysis and Forecasts, by Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
8.3.1. Hospital Pharmacies
8.3.2. Retail Pharmacies
8.3.3. Online Pharmacies
8.4. Global COPD Drug Delivery Devices Market Attractiveness, by Distribution Channel
9. Global COPD Drug Delivery Devices Market Analysis and Forecasts, by Region
9.1. Key Findings
9.2. Global COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global COPD Drug Delivery Devices Market Attractiveness, by Region
10. North America COPD Drug Delivery Devices Market Analysis and Forecast
10.1. Introduction
10.2. North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
10.2.1. Inhaler
10.2.1.1. Metered Dose Inhaler
10.2.1.2. Dry Powder Inhaler
10.2.1.3. Soft Mist Inhaler
10.2.2. Nebulizer
10.2.2.1. Jet Nebulizer
10.2.2.2. Mesh Nebulizer
10.2.2.3. Ultrasonic Nebulizer
10.3. North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017–2027
10.3.1. Manual Device
10.3.2. Digital Device
10.4. North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
10.5.1. U.S.
10.5.2. Canada
10.6. North America COPD Drug Delivery Devices Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Type
10.6.3. By Distribution Channel
10.6.4. By Country
11. Europe COPD Drug Delivery Devices Market Analysis and Forecast
11.1. Introduction
11.2. Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
11.2.1. Inhaler
11.2.1.1. Metered Dose Inhaler
11.2.1.2. Dry Powder Inhaler
11.2.1.3. Soft Mist Inhaler
11.2.2. Nebulizer
11.2.2.1. Jet Nebulizer
11.2.2.2. Mesh Nebulizer
11.2.2.3. Ultrasonic Nebulizer
11.3. Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017–2027
11.3.1. Manual Device
11.3.2. Digital Device
11.4. Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe COPD Drug Delivery Devices Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Type
11.6.3. By Distribution Channel
11.6.4. By Country/Sub-region
12. Asia Pacific COPD Drug Delivery Devices Market Analysis and Forecast
12.1. Introduction
12.2. Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
12.2.1. Inhaler
12.2.1.1. Metered Dose Inhaler
12.2.1.2. Dry Powder Inhaler
12.2.1.3. Soft Mist Inhaler
12.2.2. Nebulizer
12.2.2.1. Jet Nebulizer
12.2.2.2. Mesh Nebulizer
12.2.2.3. Ultrasonic Nebulizer
12.3. Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017–2027
12.3.1. Manual Device
12.3.2. Digital Device
12.4. Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific COPD Drug Delivery Devices Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Type
12.6.3. By Distribution Channel
12.6.4. By Country/Sub-region
13. Latin America COPD Drug Delivery Devices Market Analysis and Forecast
13.1. Introduction
13.2. Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
13.2.1. Inhaler
13.2.1.1. Metered Dose Inhaler
13.2.1.2. Dry Powder Inhaler
13.2.1.3. Soft Mist Inhaler
13.2.2. Nebulizer
13.2.2.1. Jet Nebulizer
13.2.2.2. Mesh Nebulizer
13.2.2.3. Ultrasonic Nebulizer
13.3. Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017–2027
13.3.1. Manual Device
13.3.2. Digital Device
13.4. Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America COPD Drug Delivery Devices Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Type
13.6.3. By Distribution Channel
13.6.4. By Country/Sub-region
14. Middle East & Africa COPD Drug Delivery Devices Market Analysis and Forecast
14.1. Introduction
14.2. Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
14.2.1. Inhaler
14.2.1.1. Metered Dose Inhaler
14.2.1.2. Dry Powder Inhaler
14.2.1.3. Soft Mist Inhaler
14.2.2. Nebulizer
14.2.2.1. Jet Nebulizer
14.2.2.2. Mesh Nebulizer
14.2.2.3. Ultrasonic Nebulizer
14.3. Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017–2027
14.3.1. Manual Device
14.3.2. Digital Device
14.4. Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
14.4.1. Hospital Pharmacies
14.4.2. Retail Pharmacies
14.4.3. Online Pharmacies
14.5. Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Israel
14.5.4. Rest of Middle East & Africa
14.6. Middle East & Africa COPD Drug Delivery Devices Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Type
14.6.3. By Distribution Channel
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Competition Matrix
15.2. Market Share Analysis, by Company (2018)
15.3. Company Profiles
15.3.1. AstraZeneca
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Company Financials
15.3.1.3. Growth Strategies
15.3.1.4. SWOT Analysis
15.3.2. Boehringer Ingelheim GmbH
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Company Financials
15.3.2.3. Growth Strategies
15.3.2.4. SWOT Analysis
15.3.3. GlaxoSmithKline plc
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Company Financials
15.3.3.3. Growth Strategies
15.3.3.4. SWOT Analysis
15.3.4. Novartis AG
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Company Financials
15.3.4.3. Growth Strategies
15.3.4.4. SWOT Analysis
15.3.5. Teva Pharmaceutical Industries
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Company Financials
15.3.5.3. Growth Strategies
15.3.5.4. SWOT Analysis
15.3.6. Merck & Co., Inc.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Company Financials
15.3.6.3. Growth Strategies
15.3.6.4. SWOT Analysis
15.3.7. Cipla Inc.
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Company Financials
15.3.7.3. Growth Strategies
15.3.7.4. SWOT Analysis
15.3.8. Sunovion Pharmaceuticals, Inc.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Company Financials
15.3.8.3. Growth Strategies
15.3.8.4. SWOT Analysis
15.3.9. Koninklijke Philips N.V.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Company Financials
15.3.9.3. Growth Strategies
15.3.9.4. SWOT Analysis
15.3.10. PARI GmbH
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Growth Strategies
15.3.10.3. SWOT Analysis
15.3.11. Omron Corporation
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Company Financials
15.3.11.3. Growth Strategies
15.3.11.4. SWOT Analysis
List of Tables
Table 01: Global COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 02: Global COPD Drug Delivery Devices Market, by Inhaler, 2017–2027
Table 03: Global COPD Drug Delivery Devices Market, by Nebulizer, 2017–2027
Table 04: Global COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017–2027
Table 05: Global COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 06: Global COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 07: North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 08: North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Inhaler, 2017–2027
Table 09: North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Nebulizer, 2017–2027
Table 10: North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017–2027
Table 11: North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 12: North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 13: Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 14: Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Inhaler, 2017–2027
Table 15: Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Nebulizer, 2017–2027
Table 16: Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017–2027
Table 17: Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 18: Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 19: Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 20: Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Inhaler, 2017–2027
Table 21: Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Nebulizer, 2017–2027
Table 22: Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017–2027
Table 23: Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 24: Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 25: Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 26: Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Inhaler, 2017–2027
Table 27: Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Nebulizer, 2017–2027
Table 28: Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017–2027
Table 29: Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 30: Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 31: Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 32: Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Inhaler, 2017–2027
Table 33: Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Nebulizer, 2017–2027
Table 34: Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017–2027
Table 35: Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 36: Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
List of Figures
Figure 01: Global COPD Drug Delivery Devices Market Value (US$ Mn) and Distribution, by Region, 2018 and 2027
Figure 02: Global COPD Drug Delivery Devices Market Value Share, by Product, 2018
Figure 03: Global COPD Drug Delivery Devices Market Value Share, by Type, 2018
Figure 04: Global COPD Drug Delivery Devices Market Value Share, by Distribution Channel, 2018
Figure 05: Global COPD Drug Delivery Devices Market Value Share, by Region, 2018
Figure 06: Global COPD Drug Delivery Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 07: Global COPD Drug Delivery Devices Market Value Share Analysis, by Product, 2018 and 2027
Figure 08: Global COPD Drug Delivery Devices Market Value (US$ Mn) and Y-o-Y Growth, by Inhaler, 2017–2027
Figure 09: Global COPD Drug Delivery Devices Market Value (US$ Mn) and Y-o-Y Growth, by Nebulizer, 2017–2027
Figure 10: Global COPD Drug Delivery Devices Market Attractiveness Analysis, by Product, 2019–2027
Figure 11: Global COPD Drug Delivery Devices Market Value Share Analysis, by Type, 2018 and 2027
Figure 12: Global COPD Drug Delivery Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Manual Device, 2017–2027
Figure 13: Global COPD Drug Delivery Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Digital Device, 2017–2027
Figure 14: Global COPD Drug Delivery Devices Market Attractiveness Analysis, by Type, 2019–2027
Figure 15: Global COPD Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 16: Global COPD Drug Delivery Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Retail Pharmacies, 2017–2027
Figure 17: Global COPD Drug Delivery Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospital Pharmacies, 2017–2027
Figure 18: Global COPD Drug Delivery Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Online Pharmacies, 2017–2027
Figure 19: Global COPD Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel, 2019–2027
Figure 20: Global COPD Drug Delivery Devices Market Value Share Analysis, by Region, 2018 and 2027
Figure 21: Global COPD Drug Delivery Devices Market Attractiveness Analysis, by Region, 2019–2027
Figure 22: North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 23: North America COPD Drug Delivery Devices Market Value Share Analysis, by Product, 2018 and 2027
Figure 24: North America COPD Drug Delivery Devices Market Attractiveness Analysis, by Product, 2019–2027
Figure 25: North America COPD Drug Delivery Devices Market Value Share Analysis, by Type, 2018 and 2027
Figure 26: North America COPD Drug Delivery Devices Market Attractiveness Analysis, by Type, 2019–2027
Figure 27: North America COPD Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 28: North America COPD Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel, 2019–2027
Figure 29: North America COPD Drug Delivery Devices Market Value Share Analysis, by Country, 2018 and 2027
Figure 30: North America COPD Drug Delivery Devices Market Attractiveness Analysis, by Country, 2019–2027
Figure 31: Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 32: Europe COPD Drug Delivery Devices Market Value Share Analysis, by Product, 2018 and 2027
Figure 33: Europe COPD Drug Delivery Devices Market Attractiveness Analysis, by Product, 2019–2027
Figure 34: Europe COPD Drug Delivery Devices Market Value Share Analysis, by Type, 2018 and 2027
Figure 35: Europe COPD Drug Delivery Devices Market Attractiveness Analysis, by Type, 2019–2027
Figure 36: Figure 36: Europe COPD Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 37: Europe COPD Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel, 2019–2027
Figure 38: Europe COPD Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 39: Europe COPD Drug Delivery Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 40: Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 41: Asia Pacific COPD Drug Delivery Devices Market Value Share Analysis, by Product, 2018 and 2027
Figure 42: Asia Pacific COPD Drug Delivery Devices Market Attractiveness Analysis, by Product, 2019–2027
Figure 43: Asia Pacific COPD Drug Delivery Devices Market Value Share Analysis, by Type, 2018 and 2027
Figure 44: Asia Pacific COPD Drug Delivery Devices Market Attractiveness Analysis, by Type, 2019–2027
Figure 45: Asia Pacific COPD Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 46: Asia Pacific COPD Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel, 2019–2027
Figure 47: Asia Pacific COPD Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 48: Asia Pacific COPD Drug Delivery Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 49: Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 50: Latin America COPD Drug Delivery Devices Market Value Share Analysis, by Product, 2018 and 2027
Figure 51: Latin America COPD Drug Delivery Devices Market Attractiveness Analysis, by Product, 2019–2027
Figure 52: Latin America COPD Drug Delivery Devices Market Value Share Analysis, by Type, 2018 and 2027
Figure 53: Latin America COPD Drug Delivery Devices Market Attractiveness Analysis, by Type, 2019–2027
Figure 54: Latin America COPD Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 55: Latin America COPD Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel, 2019–2027
Figure 56: Latin America COPD Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 57: Latin America COPD Drug Delivery Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 58: Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 59: Middle East & Africa COPD Drug Delivery Devices Market Value Share Analysis, by Product, 2018 and 2027
Figure 60: Middle East & Africa COPD Drug Delivery Devices Market Attractiveness Analysis, by Product, 2019–2027
Figure 61: Middle East & Africa COPD Drug Delivery Devices Market Value Share Analysis, by Type, 2018 and 2027
Figure 62: Middle East & Africa COPD Drug Delivery Devices Market Attractiveness Analysis, by Type, 2019–2027
Figure 63: Middle East & Africa COPD Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 64: Middle East & Africa COPD Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel, 2019–2027
Figure 65: Middle East & Africa COPD Drug Delivery Devices Market Value Share Analysis, by Country/Sub region, 2018 and 2027
Figure 66: Middle East & Africa COPD Drug Delivery Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 67: Global COPD Drug Delivery Devices Market Share, by Company, 2018
Figure 68: AstraZeneca Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 69: AstraZeneca Respiratory Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 70: AstraZeneca Breakdown of Net Sales (%), by Product Segment, 2018
Figure 71: Boehringer Ingelheim International GmbH Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 72: Boehringer Ingelheim International GmbH R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 73: Boehringer Ingelheim International GmbH Breakdown of Net Sales (%), by Region, 2018
Figure 74: Boehringer Ingelheim International GmbH Breakdown of Net Sales (%), by Business Segment, 2018
Figure 75: GlaxoSmithKline plc Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 76: GlaxoSmithKline plc R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 77: GlaxoSmithKline plc Breakdown of Net Sales (%), by Region, 2018
Figure 78: GlaxoSmithKline plc Breakdown of Net Sales (%), by Business Segment, 2018
Figure 79: Novartis AG Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 80: Novartis AG R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 81: Novartis AG Breakdown of Net Sales (%), by Country, 2018
Figure 82: Novartis AG Breakdown of Net Sales (%), by Business Segment, 2018
Figure 83: Teva Pharmaceutical Industries Ltd. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 84: Teva Pharmaceutical Industries Ltd. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017
Figure 85: Teva Pharmaceutical Industries Ltd. Breakdown of Net Sales (%), by Segment, 2018
Figure 86: Merck & Co., Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 87: Merck & Co., Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 88: Merck & Co., Inc. Breakdown of Net Sales (%), by Region, 2018
Figure 89: Merck & Co., Inc. Breakdown of Net Sales (%), by Business Segment, 2018
Figure 90: Cipla Inc., Revenue (US$ Mn), 2015–2018
Figure 91: Cipla Inc., Breakdown of Net Sales (%), Therapy-wise, 2018
Figure 92: Cipla Inc., Breakdown of Net Sales (%), by Region, 2018
Figure 93: Sumitomo Dainippon Pharma Co., Ltd Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 94: Sumitomo Dainippon Pharma Co., Ltd R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 95: Sumitomo Dainippon Pharma Co., Ltd Breakdown of Pharmaceutical Net Sales (%), by Region, 2017
Figure 96: Sumitomo Dainippon Pharma Co., Ltd Breakdown of Net Sales (%), by Product Segment, 2017
Figure 97: Koninklijke Philips N.V. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 98: Koninklijke Philips N.V. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 99: Koninklijke Philips N.V. Breakdown of Net Sales (%), by Region, 2018
Figure 100: Koninklijke Philips N.V. Breakdown of Net Sales (%), by Business Segment, 2018
Figure 101: Omron Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 102: Omron Corporation (Healthcare Business) R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 103: Omron Corporation (Healthcare Business) Breakdown of Net Sales (%), by Region, 2018
Figure 104: Omron Corporation Breakdown of Net Sales (%), by Business Segment, 2018
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
COPD Drug Delivery Devices Market
